(CDZ) iShares S&P/TSX Canadian - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA46433F1062

Canadian, Dividend, Equity, ETF, Investments

Description: CDZ iShares S&P/TSX Canadian

The iShares S&P/TSX Canadian Dividend Aristocrats Index ETF (CDZ) is a Canadian equity ETF that tracks the performance of dividend-paying stocks with a history of consistent dividend growth. It is designed to provide investors with a stable source of income and long-term capital appreciation.

CDZ achieves this by tracking the S&P/TSX Canadian Dividend Aristocrats Index, which comprises Canadian companies that have increased their dividend payouts for at least five consecutive years. The ETFs portfolio is diversified across various sectors, with a focus on established companies with a strong track record of dividend growth.

From a technical analysis perspective, CDZ has been exhibiting a bullish trend, with its short-term and long-term moving averages indicating a positive momentum. The ETFs price has been trading above its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, and SMA200), suggesting a strong uptrend. The Average True Range (ATR) indicates a relatively low volatility, which may appeal to income-seeking investors.

Using the available technical and fundamental data, a forecast for CDZ can be made. Given the current price of 37.09 CAD, the SMA20 at 36.99 CAD, and the SMA50 at 35.89 CAD, it is likely that CDZ will continue its upward trend. The 52-week high and low of 37.33 CAD and 30.07 CAD, respectively, suggest that the ETF is currently trading near its all-time high. With an AUM of 916.28M CAD, CDZ has a sizable presence in the Canadian ETF market. Assuming the current dividend-paying trend continues, and the underlying index remains healthy, CDZ may potentially reach 38.50 CAD in the near term, representing a 4% increase from its current price.

Its worth noting that the ETFs investment objective is to provide long-term capital appreciation and income, making it suitable for investors seeking stable returns. However, as with any investment, there are risks involved, and investors should carefully evaluate their individual financial goals and risk tolerance before investing in CDZ.

Additional Sources for CDZ ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CDZ ETF Overview

Market Cap in USD 713m
Category Canadian Dividend and Income Equity
IPO / Inception 2006-09-08

CDZ ETF Ratings

Growth Rating 72.3
Fundamental -
Dividend Rating 70.9
Rel. Strength 5.71
Analysts -
Fair Price Momentum 39.75 CAD
Fair Price DCF -

CDZ Dividends

Dividend Yield 12m 3.78%
Yield on Cost 5y 6.88%
Annual Growth 5y 4.66%
Payout Consistency 94.1%
Payout Ratio %

CDZ Growth Ratios

Growth Correlation 3m 98.9%
Growth Correlation 12m 53.5%
Growth Correlation 5y 81.8%
CAGR 5y 13.66%
CAGR/Max DD 5y 0.80
Sharpe Ratio 12m 2.91
Alpha 11.97
Beta 0.328
Volatility 7.52%
Current Volume 29.4k
Average Volume 20d 13k
Stop Loss 36.8 (-2.9%)
What is the price of CDZ shares?
As of July 18, 2025, the stock is trading at CAD 37.90 with a total of 29,445 shares traded.
Over the past week, the price has changed by +0.08%, over one month by +2.34%, over three months by +11.71% and over the past year by +18.83%.
Is iShares S&P/TSX Canadian a good stock to buy?
Yes. Based on ValueRay's Analyses, iShares S&P/TSX Canadian (TO:CDZ) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 72.25 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CDZ is around 39.75 CAD . This means that CDZ is currently overvalued and has a potential downside of 4.88%.
Is CDZ a buy, sell or hold?
iShares S&P/TSX Canadian has no consensus analysts rating.
What are the forecasts for CDZ share price target?
According to our own proprietary Forecast Model, CDZ iShares S&P/TSX Canadian will be worth about 43.6 in July 2026. The stock is currently trading at 37.90. This means that the stock has a potential upside of +14.99%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 43.6 15%